| |
 |
|
Home > Pharmaceuticals & Biotechnology > Animal Health > Global Animal Health Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
|
Global Animal Health Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
|
 |
|
 |
The report is designed to provide the animal health industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. The study's major objectives include: - To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world's leading animal health companies.
- To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement organizations' internal competitor information gathering efforts by providing strategic analysis, data interpretation, and insight.
- To identify the least competitive market niches with significant growth potential.
Contains 400 pages and 55 tables
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $12500.00
Other Formats: Global PDF, DataPack
|
 |
| |
|
 |
| |
|
|
|